Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children
Journal Title: Iranian Journal of Blood and Cancer - Year 2015, Vol 7, Issue 5
Abstract
Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt treatment to the patient to prevent these long term toxicities. This challenge has resulted in the development of different strategies aimed at recognizing the optimal balance between preserving overall survival and avoidance of long-term treatment-related morbidity. Strategies in children could be quite different from those used for adults with HL. More defined risk stratification through imaging studies and biologic markers have been developped. Increased knowledge of the biology of HL have led to the introduction of targeted therapies in both the frontline and relapsed patients. Collaborative multicenter studies are required to develop new combination therapies for children with newly diagnosed and refractory HL.
Authors and Affiliations
Odile Oberlin, Catherine Patte
Keywords
Related Articles
- EP ID EP281462
- DOI -
- Views 91
- Downloads 0
Absorption Spectra of Normal Adults and Patients with Sickle Cell Anaemia Haemoglobins Treated with Hydrogen Peroxide at Two pH Values
Background: The aim of the present study was application of haemoglobin absorption spectroscopy as a distinguishing tool for identification of two haemoglobin types-HbA and HbS. Material and Methods: Millimolar absorptiv...
Bone Involvement in Neuroblastoma
This article has no abstract.
Imerslund-Grasbeck Syndrome: A Case Report
This article has no abstract.
The Difference in Initial Leukocyte Count, Bone Marrow Blast Cell Count and CD 34 Expression in Patients with Acute Myeloid Leukemia with and without NPM1 gene Mutation
Background: Mutation in NPM1 gene has been reported to be the most common genetic mutation in de novo acute myeloid leukemia (AML). AML with NPM1 gene mutation usually presents with higher initial leukocyte and blast cel...
Rhabdomyosarcoma of the Lower Eye Fornix and Conjunctiva in a Child
This article has no abstract.